Where Will Pfizer Be in 5 Years?

In later stages of the pandemic, sales of coronavirus products flagged. To add to this bad news, investors focused on ...

BridgeBio Says Pfizer, Alnylam Aren’t Playing Fair in Blockbuster Race

BridgeBio Pharma Inc. is challenging Pfizer Inc. and Alnylam Pharmaceuticals, Inc. with a heart medicine that it says has better results at a lower cost. But it claims rivals are using questionable ...

Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering.

Weight loss drugs have represented an enormous growth area for biotech and pharma companies over the past couple of years.
Zacks Investment Research on MSN

Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
BioSpace

Pfizer Stages Obesity Comeback With $4.9B Metsera Acquisition

The acquisition of breakout obesity star Metsera should pump new life into Pfizer's portfolio, which over the last two years ...
Forbes

Buy Pfizer Stock At $24?

SureCare Pharmacy manager Oscar Uribe shows off a package of Pfizer Paxlovid pills inside of Esperanza Health Center in Chicago on Jan. 13, 2022. Pfizer's Paxlovid is a treatment for COVID-19. (Chris ...

FDA approves updated Pfizer COVID shots but limits access for some kids and adults

Parents will still be able to seek out shots from rival drugmaker Moderna, the other maker of mRNA vaccines, which has full FDA approval for children as young as 6 months. But the company’s Spikevax ...